Target intelligence / Profile preview

Intestinal mucosal and epithelial surface niches

Molecular classification
Other
01

Overview

The intestinal mucosal and epithelial surface niches are specialized microenvironments within the gastrointestinal tract that facilitate the interaction between the host's epithelial lining, the underlying lamina propria, and the luminal microbiota (Nature Reviews Gastroenterology & Hepatology, 2020). These niches are essential for maintaining the intestinal barrier, which prevents the translocation of pathogens while allowing for the absorption of nutrients and water (Frontiers in Immunology, 2018). They also serve as the primary site for mucosal immunity, where specialized cells like M cells and dendritic cells sample antigens to educate the immune system (Cell Stem Cell, 2017). Within these niches, intestinal stem cells reside in the crypts, supported by a complex array of growth factors and stromal signals that ensure continuous epithelial renewal (Nature, 2011). In diseases such as inflammatory bowel disease (IBD) and celiac disease, the integrity of these niches is compromised, leading to chronic inflammation, dysbiosis, and tissue damage (PubMed, PMID: 30215168). While the niche itself is a multi-component environment rather than a single molecular target, it is the focal point for therapies aimed at mucosal healing, microbiome modulation, and local immune suppression (Gastroenterology, 2019). Drugs like vedolizumab target the trafficking of immune cells to these specific niches, while local agents like mesalamine act directly on the mucosal surface to reduce inflammation (Lancet, 2014).

Other names
Gut mucosal nicheIntestinal epithelial nicheIntestinal stem cell nicheMucosal microenvironmentIntestinal mucosal barrier
02

Mechanism of action

Modulation of the local microenvironment, restoration of epithelial barrier integrity, and suppression of mucosal inflammation.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationCancerInfectionOther
05

Safety considerations

Disruption of commensal microbiotaSystemic absorption of local agentsRisk of opportunistic infectionsMucosal fibrosis
06

Interacting drugs

Mesalamine

5 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal lactoferrinZonulinC-reactive protein

Beyond the preview

Go deeper on Intestinal mucosal and epithelial surface niches.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mucosal and epithelial surface niches.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call